|
RPL18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.804700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.418160E-03 |
| Normal-vs-Stage2 |
1.706440E-01 |
| Normal-vs-Stage3 |
1.216880E-03 |
| Normal-vs-Stage4 |
3.822000E-03 |
| Stage1-vs-Stage2 |
7.064400E-01 |
| Stage1-vs-Stage3 |
3.063800E-01 |
| Stage1-vs-Stage4 |
2.688200E-01 |
| Stage2-vs-Stage3 |
3.334000E-01 |
| Stage2-vs-Stage4 |
2.851000E-01 |
| Stage3-vs-Stage4 |
7.838800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.446000E-04 |
| Normal-vs-AfricanAmerican |
2.368800E-01 |
| Normal-vs-Asian |
1.534080E-02 |
| Caucasian-vs-AfricanAmerican |
3.596400E-01 |
| Caucasian-vs-Asian |
5.539400E-01 |
| AfricanAmerican-vs-Asian |
2.457800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.229730E-04 |
| Normal-vs-Female |
1.739360E-03 |
| Male-vs-Female |
9.754100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.420400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.757840E-03 |
| Normal-vs-Age(61-80Yrs) |
1.254210E-02 |
| Normal-vs-Age(81-100Yrs) |
1.134610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.761600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.733400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.809800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.961000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.097800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.945800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.630400E-01 |
| Classical-VS-Follicular |
5.354600E-01 |
| Classical-VS-Other |
3.930000E-01 |
| Classical-VS-Normal |
1.320580E-03 |
| Tall-VS-Follicular |
7.190000E-01 |
| Tall-VS-Other |
3.512600E-01 |
| Tall-VS-Normal |
2.783600E-02 |
| Follicular-VS-Other |
5.772400E-01 |
| Follicular-VS-Normal |
4.604600E-03 |
| Other-VS-Normal |
1.170190E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.613800E-04 |
| Normal-vs-N1 |
3.423000E-03 |
| N0-vs-N1 |
6.086200E-01 |
|
|
